265
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Symptom Burden, Health Status, and Productivity in Patients with Uncontrolled and Controlled Severe Asthma in NOVELTY

ORCID Icon, , , , , ORCID Icon & ORCID Icon show all, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , & show all, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , & show all
Pages 611-624 | Received 14 Dec 2022, Accepted 13 Apr 2023, Published online: 11 Jun 2023

References

  • Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention; 2022. Available from: https://ginasthma.org/reports/. Accessed 30, June, 2022.
  • Nurmagambetov T, Kuwahara R, Garbe P. The Economic Burden of Asthma in the United States, 2008-2013. Ann Am Thorac Soc. 2018;15(3):348–356. doi:10.1513/AnnalsATS.201703-259OC
  • Müllerová H, Cockle SM, Gunsoy NB, Nelsen LM, Albers FC. Clinical characteristics and burden of illness among adolescent and adult patients with severe asthma by asthma control: the IDEAL study. J Asthma. 2021;58(4):459–470. doi:10.1080/02770903.2019.1708095
  • Sadatsafavi M, Lynd L, Marra C, et al. Direct health care costs associated with asthma in British Columbia. Can Respir J. 2010;17(2):74–80. doi:10.1155/2010/361071
  • Dolan CM, Fraher KE, Bleecker ER, et al. Design and baseline characteristics of the epidemiology and natural history of asthma: outcomes and Treatment Regimens (TENOR) study: a large cohort of patients with severe or difficult-to-treat asthma. Ann Allergy Asthma Immunol. 2004;92(1):32–39. doi:10.1016/S1081-1206(10)61707-3
  • Haselkorn T, Szefler SJ, Chipps BE, et al. Disease Burden and Long-Term Risk of Persistent Very Poorly Controlled Asthma: TENOR II. J Allergy Clin Immunol Pract. 2020;8(7):2243–2253. doi:10.1016/j.jaip.2020.02.040
  • Lucas C, Aly S, Touboul C, Sellami R, Guillaume X, Garcia G. Patient-Reported Outcome in Two Chronic Diseases: a Comparison of Quality of Life and Response Profiles in Severe Migraine and Severe Asthma. Patient Relat Outcome Meas. 2020;11:27–37. doi:10.2147/PROM.S222597
  • Stewart J, Kee F, Hart N. Using routinely collected primary care records to identify and investigate severe asthma: a scoping review. NPJ Prim Care Respir Med. 2021;31(1):1. doi:10.1038/s41533-020-00213-9
  • Lee LK, Ramakrishnan K, Safioti G, Ariely R, Schatz M. Asthma control is associated with economic outcomes, work productivity and health-related quality of life in patients with asthma. BMJ Open Respir Res. 2020;7(1):e000534. doi:10.1136/bmjresp-2019-000534
  • Reddel HK, Gerhardsson de Verdier M, Agustí A, et al. Prospective observational study in patients with obstructive lung disease: NOVELTY design. ERJ Open Res. 2019;5(1):00036–02018. doi:10.1183/23120541.00036-2018
  • Reddel HK, Vestbo J, Agustí A, et al. Heterogeneity within and between physician-diagnosed asthma and/or COPD: NOVELTY cohort. Eur Respir J. 2021;58(3):2003927. doi:10.1183/13993003.03927-2020
  • Schatz M, Sorkness CA, Li JT, et al. Asthma Control Test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists. J Allergy Clin Immunol. 2006;117(3):549–556. doi:10.1016/j.jaci.2006.01.011
  • Fletcher CM, Clifton M, Fairbairn AS, et al. Standardized questionnaires on respiratory symptoms: a statement prepared for, and approved by, the Medical Research Council’s Committee on the Aetiology of Chronic Bronchitis. BMJ. 1960;2(5213):1665.
  • Karlsson N, Atkinson MJ, Müllerová H, et al. Validation of a diagnosis-agnostic symptom questionnaire for asthma and/or COPD. ERJ Open Res. 2021;7(1):00828–02020. doi:10.1183/23120541.00828-2020
  • Nathan RA, Sorkness CA, Kosinski M, et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol. 2004;113(1):59–65. doi:10.1016/j.jaci.2003.09.008
  • Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Prevention, Diagnosis and Management of COPD: 2023 Report. 2022. Available from: https://goldcopd.org/2023-gold-report-2/. Accessed April 17, 2023.
  • Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George’s Respiratory Questionnaire. Am Rev Respir Dis. 1992;145(6):1321–1327. doi:10.1164/ajrccm/145.6.1321
  • Tomaszewski E, Atkinson MJ, Janson C, et al. Chronic Airways Assessment Test: psychometric properties in patients with asthma and/or COPD. Respir Res. 2023;24(1):106. doi:10.1186/s12931-023-02394-6
  • EQ-5D. EQ-5D User Guides. Available from: https://euroqol.org/publications/user-guides. Accessed April 17, 2023.
  • Jones PW, Harding G, Berry P, Wiklund I, Chen W-H, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009;34(3):648–654. doi:10.1183/09031936.00102509
  • Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. 1993;4(5):353–365. doi:10.2165/00019053-199304050-00006
  • R Core Team. R: a language and environment for statistical computing. Available from: https://www.r-project.org/. Accessed 13, Jan 2021.
  • Barros LL, Souza-Machado A, Correa LB, et al. Obesity and poor asthma control in patients with severe asthma. J Asthma. 2011;48(2):171–176. doi:10.3109/02770903.2011.554940
  • Milanese M, Di Marco F, Corsico AG, et al. Asthma control in elderly asthmatics. An Italian observational study. Respir Med. 2014;108(8):1091–1099. doi:10.1016/j.rmed.2014.05.016
  • Jones PW. St. George’s Respiratory Questionnaire: MCID. COPD. 2005;2(1):75–79. doi:10.1081/COPD-200050513
  • McClure NS, Sayah FA, Xie F, Luo N, Johnson JA. Instrument-Defined Estimates of the Minimally Important Difference for EQ-5D-5L Index Scores. Value Health. 2017;20(4):644–650. doi:10.1016/j.jval.2016.11.015
  • Chen H, Blanc PD, Hayden ML, et al. Assessing productivity loss and activity impairment in severe or difficult-to-treat asthma. Value Health. 2008;11(2):231–239. doi:10.1111/j.1524-4733.2007.00229.x
  • Brown T, Jones T, Gove K, et al. Randomised controlled trials in severe asthma: selection by phenotype or stereotype. Eur Respir J. 2018;52:1801444. doi:10.1183/13993003.01444-2018
  • Price D, Brusselle G, Roche N, Freeman D, Chisholm A. Real-world research and its importance in respiratory medicine. Breathe. 2015;11(1):26–38. doi:10.1183/20734735.015414
  • Chung KF, Wenzel SE, Brozek JL, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43(2):343–373. doi:10.1183/09031936.00202013